A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study

Y. Chiu, C. Tang, S. Hung, Y. Yang, C. Fang, H. Lin

研究成果: 雜誌貢獻文章同行評審

13 引文 斯高帕斯(Scopus)

搜尋結果